Mapping large numbers of results may take a few moments.
Search Results
Showing 101 - 129 of 129 results found.
| Company | Activity | Company Description | Location | |
|---|---|---|---|---|
 |
Company Precision BioSciences Inc. (Durham) | Activity: Research and Development | Company Description Precision BioSciences is a clinical stage in vivo gene editing company using its novel ARCUS genome editing platform to develop new treatment options for genetic and infectious diseases. | Location Durham |
| |
Company Precision Biosciences Manufacturing Center for Advanced Therapeutics (RTP) | Activity: Production and Manufacturing | Company Description Precision BioSciences is a clinical stage in vivo gene editing company using its novel ARCUS genome editing platform to develop new treatment options for genetic and infectious diseases. | Location Research Triangle Park |
| |
Company Precision Diabetes Inc. | Activity: Sales and Operations | Company Description Precision Diabetes is developing a spectrum of unique diabetes tests, from detecting the risk of developing diabetes to diagnosing complications from diabetes. | Location Cary |
| |
Company ProKidney (Winston-Salem) | Activity: Production and Manufacturing | Company Description ProKidney manufactures cell therapy products that use a patient's own cells to restore damaged kidney tissues by engrafting into, repairing or replacing damaged tissues or organs. | Location Winston-Salem |
| |
Company Q² Solutions | Activity: Contract Research and Testing | Company Description Q² Solutions provides global clinical trial laboratory services including comprehensive testing, project management, supply chain, biospecimen and consent management solutions. | Location Morrisville |
| |
Company RainBio Inc. | Activity: Research and Development | Company Description RainBio is developing AAV (adeno-associated virus) gene therapy corneal treatments to address the unmet need of treatment of rare corneal blinding diseases. | Location Raleigh |
| |
Company Resilience (Durham) | Activity: Production and Manufacturing | Company Description Resilience manufactures viral vectors, a component of cell and gene therapies. | Location Durham |
| |
Company Sanesco International Inc. | Activity: Research and Development | Company Description Sanesco develops clinical tools for healthcare providers, such as neuroendocrine analytical testing, nutritional support formulas and patient-centered clinical review. The NeuroLab division conducts research and development of in vitro diagnostic tools. | Location Arden |
| |
Company Sapere Bio Inc. | Activity: Research and Development | Company Description Sapere Bio develops biomarkers of aging for clinical use to help physicians predict risk of chemotherapy-induced toxicities and surgery-associated adverse events in various patient groups. | Location Research Triangle Park |
| |
Company Sarepta Therapeutics Inc. (Durham) | Activity: Research and Development | Company Description Sarepta Therapeutics develops precision genetic medicine treatments for Duchenne muscular dystrophy (DMD), Limb-girdle muscular dystrophy (LGMD) and other central nervous system (CNS) disorders. Sarepta's Gene Editing Innovation Center is in Durham. | Location Durham |
| |
Company ScitoVation LLC | Activity: Contract Research and Testing | Company Description ScitoVation supports and advances research on the effects of chemical compounds on human health. ScitoVation works with clients to develop safer pharmaceuticals, food ingredients, agricultural chemicals, commodity chemicals and consumer products. | Location Durham |
| |
Company SmartGene Inc. | Activity: Support and Related | Company Description SmartGene provides web-based software solutions for the management, analysis and interpretation of genetic sequences to identify and characterize bacteria, fungi and viruses. Customers include diagnostic labs, medical centers and sterile manufacturers. | Location Raleigh |
| |
Company SNP Therapeutics LLC | Activity: Research and Development | Company Description SNP Therapeutics develops genetic tests to identify genetic variant patterns that contribute to disease. SNPT also designs nutritional therapeutics to treat metabolic disorders. | Location Kannapolis |
| |
Company Sumitomo Pharma America Inc. (Cary) | Activity: Research and Development | Company Description Sumitomo Pharma America develops regenerative therapeutics for rare diseases such as congenital athymia. | Location Cary |
| |
Company Tavros Therapeutics Inc. | Activity: Research and Development | Company Description Tavros is developing first-in-class therapeutics for cancer by using a novel precision oncology platform. | Location Research Triangle Park |
| |
Company Taylor's Tale | Activity: Support and Related | Company Description Taylor's Tale supports patients of rare diseases and their families, funds treatments and advocates for legislation. | Location Charlotte |
| |
Company Taysha Gene Therapies Inc. | Activity: Production and Manufacturing | Company Description Taysha Gene Therapies develops and manufactures gene therapies for the treatment of monogenic diseases of the central nervous system (CNS), both in rare and large patient populations. | Location Research Triangle Park |
| |
Company Tellus Therapeutics Inc. | Activity: Research and Development | Company Description Tellus Therapeutics is developing novel small molecules derived from human maternal breast milk for the treatment of newborns with perinatal brain injury. | Location Research Triangle Park |
| |
Company Tempus Labs Inc. | Activity: Contract Research and Testing | Company Description Tempus is a technology company advancing precision medicine through application of artificial intelligence in healthcare. The company's clinical laboratory in RTP supports next-generation sequencing workflows by manufacturing and processing samples. | Location Durham |
| |
Company Ten63 Therapeutics Inc. | Activity: Research and Development | Company Description Ten63 Therapeutics uses computational chemistry and AI to screen trillions of molecules to discover new therapeutics for a wide variety of diseases. | Location Durham |
| |
Company TheraSplice | Activity: Research and Development | Company Description TheraSplice is developing a precision oncology platform and products. The company has several targets under development in prostate, lung, breast, and liver cancer with the goal of initiating biomarker stratified clinical trials. | Location Chapel Hill |
| |
Company Torque Bio Inc. | Activity: Research and Development | Company Description Torque Bio is a start-up leveraging the power of technology to develop novel gene therapies. | Location Durham |
| |
Company TregTherapeutics Inc. | Activity: Research and Development | Company Description TregTherapeutics develops tolerogenic therapies to treat autoimmune disease. The approach uses endogenous antigens to personalize therapy for any patient and/or disease. | Location Chapel Hill |
| |
Company Tune Therapeutics | Activity: Research and Development | Company Description Tune Therapeutics develops novel cell and gene therapy products with their epigenome editing and gene regulation platform, TEMPO. | Location Durham |
| |
Company uMETHOD Health Inc. | Activity: Support and Related | Company Description uMethod Health analyzes medical data to identify underlying causes of disease and develop evidence-based personalized care plans to improve outcomes for patients living with chronic diseases. | Location Raleigh |
| |
Company Validic | Activity: Support and Related | Company Description Validic offers health IOT and remote care enablement platform solutions for payers, health systems, health IT, and pharma. | Location Chapel Hill |
| |
Company Xilis Inc. | Activity: Research and Development | Company Description Xilis is developing microfluidic droplet-based patient-derived organoid (MDPDO) technology to guide precision therapy for cancer patients and accelerate drug discovery. | Location Durham |
| |
Company ZealCare Inc. | Activity: Support and Related | Company Description ZealCare is a tech-enabled disease management company that partners with accountable care organizations and health systems to offer personalized health care for people with complex chronic diseases. | Location Cary |
| |
Company Zinfandel Pharmaceuticals Inc. | Activity: Research and Development | Company Description Zinfandel Pharmaceuticals uses pharmacogenetics to improve prediction of risk for Alzheimer’s disease and facilitate the development of effective therapies. | Location Chapel Hill |